1 Min Read
DUBLIN, Feb 6 (Reuters) - Elan Corporation PLC : * Announces that it has agreed to restructure the tysabri collaboration with
Biogen Idec Inc * Says posted FY revenues $1.2 billion, adjusted EBITDA increased by over 30
percent to $220 million
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.